Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

New Crypto Mutuum Finance (MUTM) Reaches Over 18,700 Investors and $19.8M Raises as Protocol Launch Nears

January 18, 2026

Political analyst reacts to Canada’s tariff deal with China

January 17, 2026

Langdon residents step up to help family displaced by fire

January 17, 2026

Canada launches compensation program for banned assault-style firearms

January 17, 2026

Disney deleted a Thread because people kept quoting its movies at it

January 17, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Global Optogenetics Market Assessment 2018-2023 and Forecast 2024-2028, Featuring Key Players Hubner Group (Cobolt Inc.), Coherent Inc., and Gensight Biologics SA Among Others
Press Release

Global Optogenetics Market Assessment 2018-2023 and Forecast 2024-2028, Featuring Key Players Hubner Group (Cobolt Inc.), Coherent Inc., and Gensight Biologics SA Among Others

By News RoomJanuary 11, 20243 Mins Read
Global Optogenetics Market Assessment 2018-2023 and Forecast 2024-2028, Featuring Key Players Hubner Group (Cobolt Inc.), Coherent Inc., and Gensight Biologics SA Among Others
Share
Facebook Twitter LinkedIn Pinterest Email
Global Optogenetics Market Assessment 2018-2023 and Forecast 2024-2028, Featuring Key Players Hubner Group (Cobolt Inc.), Coherent Inc., and Gensight Biologics SA Among Others

Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) — The “Global Optogenetics Market Size, Share, Trends, Opportunity, and Forecast, 2018-2028” report has been added to ResearchAndMarkets.com’s offering.

The Global Optogenetics Market, valued at USD 545.6 million in 2022, is expected to grow significantly with a CAGR of 4.01% through 2028. Optogenetics, a revolutionary biological technique, integrates optics and genetics to control specific cells using light-sensitive opsins. Widely applied in neuroscience, its reach extends to biology, medicine, and biotechnology. Opsins, engineered into target cells, enable precise light responsiveness. Ethical considerations arise, guiding researchers in optogenetic experiments.

Optogenetics transformed neuroscience, enabling precise neural circuit control. Ongoing advancements, including improved opsins and light-delivery systems, enhance accessibility. Therapeutic potential for neurological and psychiatric disorders is explored, attracting substantial funding. Key drivers include technological innovations, multiplexing, advanced optical systems, wireless setups, miniaturization, closed-loop systems, improved viral vectors, and two-photon microscopy.

Advancements in neuroscience research, fueled by technology, collaboration, and funding, deepen understanding. Connectomics, fMRI techniques, single-cell RNA sequencing, gene editing, neuroimaging, and brain-computer interfaces are vital. Machine learning decodes neural data, and brain organoids aid realistic studies. Ethical considerations, addressed by initiatives like the Human Connectome Project, are crucial for responsible technology use.

Expanding application areas drive optogenetics demand. Initially for neuroscience, it’s applied in cardiology, optometry, regenerative medicine, pain perception studies, psychiatry, hormonal regulation, cancer research, immune cell studies, bioengineering, synthetic biology, and drug discovery. Ethical discussions rise with broader applications, boosting the Global Optogenetics Market.

Key market challenges include limited neural circuit understanding due to the brain’s complexity, variability between individuals, challenges in accessing deep brain regions, and understanding the relationship between neural activity and behavior. The cost of technology, including specialized equipment, reagents, animal studies, personnel, and ongoing operational costs, poses challenges.

Customization and targeted approaches are key trends. Researchers customize opsins, multiplexing, and cell-type specificity for precise neural circuit control. Customized optogenetic approaches for clinical applications gain significance.

Segmental insights indicate LED dominance in light equipment, Channel Rhodopsin in actuators, Chloride in sensors, and neuroscience in applications. North America leads the market due to rising chronic diseases, increased optogenetic device use in research labs, and strategic partnerships.

Key market players include:

  • Hubner Group (Cobolt Inc.)
  • Coherent Inc.
  • Gensight Biologics SA
  • Laserglow Technologies
  • Noldus Information Technology Inc.
  • Judges’ Scientific PLC (Scientifica)
  • Shanghai Laser & Optics Century Co. Ltd.
  • Bruker Corporation
  • Thorlabs Inc.

The Global Optogenetics Market, driven by innovation, expanding applications, and ethical considerations, is poised for substantial growth, offering diverse opportunities for research and therapeutic interventions.

Report Scope

In this report, the Global Optogenetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Optogenetics Market, by Light Equipment:

  • Laser
  • Light-emitting Diode

Optogenetics Market, by Actuator:

  • Channel rhodopsin
  • Halorhodopsin
  • Archaerhodopsin

Optogenetics Market, by Sensor:

  • Calcium (Aequorin, Cameleon, and Other Calcium Sensors)
  • Chloride (Clomeleon)
  • Membrane-gated (Mermaid)
  • Other Sensors

Optogenetics Market, by Application:

  • Neuroscience
  • Behavioral Tracking
  • Retinal Disease Treatment
  • Other Applications

Global Optogenetics Market, by region:

  • North America
  • Asia-Pacific
  • Europe
  • South America
  • Middle East & Africa
Report Attribute Details
No. of Pages 181
Forecast Period 2022-2028
Estimated Market Value (USD) in 2022 $545.6 Million
Forecasted Market Value (USD) by 2028 $695.85 Million
Compound Annual Growth Rate 4%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/28lpx1

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Optogenetics Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

New Crypto Mutuum Finance (MUTM) Reaches Over 18,700 Investors and $19.8M Raises as Protocol Launch Nears

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus – As Nature Intended, Ingredients

Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness

Phentermine Over the Counter Alternative 2026 – OTC Appetite Suppressant Search Trend Analysis Positions PhenQ as a Market Leader According to 1200 Doctors

Sugar Clean Drops: Top Blood Sugar Support Supplement for Metabolic Wellness and Energy Support

CryptSync Launches Insured Self-Custody Wallet With Seedless Onboarding and Social Payments

ProCryptoRecovery LTD Unveils Platform, Advancing AI-Driven Crypto Forensics and Compliance-Ready Investigations

New Crypto Mutuum Finance (MUTM) Surpasses $19.8 Million Raised With Over 18,800 Early Investors

Crypto Protocol Mutuum Finance (MUTM) Finalized Halborn Security Review as Roadmap Phase 2 Advances

Editors Picks

Political analyst reacts to Canada’s tariff deal with China

January 17, 2026

Langdon residents step up to help family displaced by fire

January 17, 2026

Canada launches compensation program for banned assault-style firearms

January 17, 2026

Disney deleted a Thread because people kept quoting its movies at it

January 17, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Canada talks trade with Qatar as Carney touches down in Doha

January 17, 2026

The Setapp Mobile iOS store is shutting down on February 16th

January 17, 2026

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus – As Nature Intended, Ingredients

January 17, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version